InvestorsHub Logo
Followers 826
Posts 119567
Boards Moderated 14
Alias Born 09/05/2002

Re: DewDiligence post# 14634

Wednesday, 11/11/2015 1:17:17 PM

Wednesday, November 11, 2015 1:17:17 PM

Post# of 20689
US patent trial on 40mg Copaxone is scheduled for 9/26/16 (new info at CS webcast today). This patent trial may be unnecessary if the USPTO IPR scheduled for 5/2/16 results in the USPTO invalidating Teva’s 40mg patents.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”